Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $7.07 Analyst target: $20.00 Upside: 182.89%
Rockwell Medical, Inc. is a biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with iron deficiency treatment and hemodialysis products and therapies in the United States and internationally. The company is headquartered in Wixom, Michigan.
See the full interactive analysis & chart →Informational only — not investment advice.